Examkin

Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

An internal medicine physician is admitting a patient with persistent, highly symptomatic atrial fibrillation. The patient, a septuagenarian with a known history of ischemic cardiomyopathy (left ventricular ejection fraction of 30%30\%), has failed an optimal rate control strategy. Following consultation with electrophysiology, the decision is made to initiate dofetilide for chemical cardioversion and rhythm maintenance.

Which of the following monitoring parameters and baseline assessments are strictly required during the initiation phase of this specific pharmacotherapy? (Select 3 correct answers)

  1. Continuous electrocardiographic telemetry for a minimum of 3 daysCevap
  2. Baseline and serial assessment of estimated creatinine clearanceCevap
  3. Serial measurement of serum potassium and magnesium levelsCevap
  4. D
    Baseline and routine monitoring of thyroid-stimulating hormone levels
  5. E
    Baseline and serial monitoring of hepatic transaminases

Cevap

The strictly required monitoring parameters are continuous electrocardiographic telemetry, serial assessment of estimated creatinine clearance, and measurement of serum potassium and magnesium levels.
Dofetilide is a potent Class III antiarrhythmic that carries a significant risk of inducing QT interval prolongation and life-threatening Torsades de Pointes (TdP). Due to this specific proarrhythmic risk, regulatory protocols mandate that patients be admitted to a facility equipped with continuous electrocardiographic monitoring (telemetry) for a minimum of 3 days (or 12 hours after electrical cardioversion, whichever is longer) to observe the QTc interval. Furthermore, dofetilide is primarily cleared by the kidneys. Toxic accumulation occurs rapidly in renal impairment, so calculating the creatinine clearance is strictly required prior to the first dose and throughout the initiation phase to appropriately adjust the dosage or withhold the drug if clearance drops below 2020 mL/min. Lastly, hypokalemia and hypomagnesemia act as severe precipitants for TdP; therefore, serial measurement of serum potassium and magnesium levels is mandatory to ensure they remain within the therapeutic range during the loading phase.

Adım Adım Çözüm

1
Identify the primary risks of the chosen drug (dofetilide).
Dofetilide is a Class III antiarrhythmic with a potent, dose-dependent risk of QT interval prolongation and Torsades de Pointes.
Understanding the adverse effect profile drives the specific inpatient monitoring requirements.
2
Determine the clearance mechanism of the drug.
Dofetilide is primarily cleared unchanged by the kidneys.
This establishes that baseline renal function (creatinine clearance) must be calculated to adjust the dose or identify contraindications.
3
Identify interacting physiological factors that exacerbate the drug's primary risk.
Low serum potassium and magnesium independently prolong the QT interval.
Maintaining electrolyte homeostasis is critical to preventing fatal arrhythmias during dofetilide initiation.
4
Exclude organ toxicities associated with different antiarrhythmic agents.
Thyroid and hepatic monitoring are excluded, as these are toxicities characteristic of amiodarone, not dofetilide.
Distinguishing between the unique toxicity profiles of antiarrhythmics prevents unnecessary and incorrect testing.

Anahtar Kavram

Dofetilide Initiation and Monitoring Protocol
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru